Market Overview

UPDATE: Morgan Stanley Reiterates Overweight Rating, Raises PT on Concord Medical Services Holdings

Related CCM
UPDATE: Morgan Stanley Reiterates On Concord Medical Services Holdings Ltd. On Unsurprising 3Q14
Earnings Scheduled For November 17, 2014

In a report published Friday, Morgan Stanley reiterated its Overweight rating on Concord Medical Services Holdings (NYSE: CCM), and raised its price target from $4.00 to $5.80.

Morgan Stanley noted, “We believe it is time to take another look at CCM after it completed the acquisition of Chang'an Hospital in 2Q12. We raise our 2013 and 2014 top-line estimates by 5% and 3% on higher hospital business sales (12e is unchanged). We increase 2012-14 non-GAAP EPS by 12%, 7%, and 9%, respectively, to Rmb3.17, Rmb2.88, and Rmb3.01, respectively. We reiterate our Overweight rating on CCM and raise our PT from US$4.00 to US$5.80.”

Concord Medical Services Holdings closed on Wednesday at $4.33.

Latest Ratings for CCM

DateFirmActionFromTo
Nov 2012Morgan StanleyMaintainsOverweight
Jul 2012Morgan StanleyMaintainsOverweight
Mar 2012JP MorganMaintainsOverweight

View More Analyst Ratings for CCM
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Price Target Analyst Ratings

 

Related Articles (CCM)

Around the Web, We're Loving...

Get Benzinga's Newsletters